Skip to content
AnalystLens

EQT 8-K Report, Financial Results (Oct 29, 2024)

Reports
Earnings & Results·Other Events·Exhibits & Filings
Filing Date
Filed October 29, 2024
Period End
October 29, 2024
Security
EQT
In the record · 2016–202610-K1210-Q348-K232

EQT filed 12 annual reports (10-K), 34 quarterly reports (10-Q) and 232 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Mar ’18Mar ’18
  2. Leadership change8-K · May ’20May ’20
  3. Material agreement8-K · Nov ’22Nov ’22
  4. Material agreement8-K · Oct ’26Oct ’26

Summary

Summary of the 8-K filed October 29, 2024. Cited figures are marked; the original filing is the authoritative source.

EQT Corporation's Q3 2024 results (furnished under Item 2.02) show a company in the first full quarter after closing its Equitrans Midstream acquisition (July 22, 2024).

Sales volume reached 581 Bcfe, above the high end of guidance, and the average realized price rose to $2.38a/Mcfe from $2.28 a year earlier. Reported net loss attributable to EQT was $(301) million, or $(0.54) per diluted share, driven largely by $280 million of other expenses, mostly acquisition-related transaction costs. Adjusted net income was $69 million ($0.12 adjusted EPS) versus $126 million ($0.30) a year earlier, and adjusted EBITDA rose to $832 million from $521 million.

Free cash flow was negative $121 millionb as capital spending of $558 million and roughly $172 million of merger cash costs outpaced adjusted operating cash flow of $522 million. Management said integration is more than 60% complete, with $145 million of annualized base synergies identified, and that per-unit operating costs fell to $1.14/Mcfe, or $1.07 pro forma. The central balance-sheet item is the agreement to sell EQT's remaining non-operated Northeast Pennsylvania natural gas interests to Equinor for $1.25 billion in cash, with an effective date of December 31, 2024 and expected closing in Q4 2024, subject to customary adjustments and regulatory approvals.

The proceeds are earmarked for debt repayment. Total debt rose to $13.8 billionc at September 30, 2024 from $5.8 billion at year-end 2023, following the Equitrans transaction, so deleveraging is the main investor focus. Management tied the sale, along with ongoing regulated midstream asset sales, to its year-end 2025 debt target and said the two divestitures announced in 2024 imply about $3.6 billion of total value on the non-operated position.

The filing also points to the company's Q4 2024 guidance, with sales volume of 555 to 605 Bcfe, total per-unit operating costs of $1.07 to $1.21d/Mcfe, and total capital expenditures of $630 to $730 million. The company is about 60% hedged for 2025 at an average floor of $3.25/Dth. Forward-looking statements flag integration execution, the timing of asset sales, leverage reduction, and commodity price risk as key uncertainties.

Key Highlights

  1. Equinor deal: agreement to sell remaining non-operated Northeast Pennsylvania gas assets (~350 MMcf/d forecast 2025 net production) for $1.25 billion cash, expected to close Q4 2024 and used for debt repayment.
  2. Leverage increase: total debt of $13.8 billion at 9/30/24 versus $5.8 billion at 12/31/23, reflecting the Equitrans acquisition; $2.0 billion drawn on the $3.5 billion revolver.
  3. Adjusted EPS of $0.12 versus $0.30 a year earlier, while GAAP diluted EPS was $(0.54) due to about $280 million of other expenses, mainly acquisition-related costs.
  4. Adjusted EBITDA rose to $832 million from $521 million, reflecting the Equitrans midstream contribution.
  5. Free cash flow was $(121) million, pressured by $558 million of capex and about $172 million of Equitrans merger cash transaction costs.
  6. Integration progress: more than 60% complete three months after closing, with $145 million of annualized base synergies (over 50% of base plan synergies).
  7. Sales volume of 581 Bcfe, above guidance, with an average realized price of $2.38/Mcfe (up from $2.28) and total per-unit operating costs of $1.14/Mcfe ($1.07 pro forma).

Frequently Asked Questions

  1. Why is EQT reporting a GAAP net loss when adjusted EBITDA increased sharply?

    The GAAP net loss of $(301) million, or $(0.54) per diluted share, was driven mainly by roughly $280 million of other expenses, which consist primarily of acquisition and strategic transaction costs tied to Equitrans. Adjusted measures exclude these items and derivative fair-value swings, so adjusted EBITDA of $832 million (up from $521 million) better reflects the operating contribution of the combined business.

  2. What will the $1.25 billion Northeast Pennsylvania sale mean for EQT's leverage?

    The company intends to apply the cash proceeds to debt repayment. Sales of this size would meaningfully reduce the $13.7 billion of net debt at September 30, 2024, though the filing does not quantify the resulting pro forma leverage. Management links the sale and regulated midstream asset sales to its year-end 2025 debt target.

  3. Is the Equinor sale subject to closing risk?

    Yes. The transaction is subject to customary purchase price adjustments and required regulatory approvals and clearances. The company expects closing in Q4 2024, with an effective date of December 31, 2024. The filing does not describe specific regulatory concerns.

  4. How is EQT positioned against commodity price risk for 2025?

    As of October 25, 2024, EQT was approximately 60% hedged for 2025 at an average floor of $3.25/Dth, with hedge positions including swaps, calls, and puts. The company also hedges basis. The hedge book is pro forma for the announced non-operated asset sale, and the company may use other agreements to implement its strategy.

  5. What are the key Q4 2024 expectations?

    Guidance calls for total sales volume of 555 to 605 Bcfe, total per-unit operating costs of $1.07 to $1.21/Mcfe, average differential of $(0.60) to $(0.50)/Mcf, and total capital expenditures of $630 to $730 million. Third-party midstream revenue is projected at $130 to $155 million.